Literature DB >> 9068465

Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?

F K Chan1, J J Sung, Y T Lee, W K Leung, L Y Chan, M Y Yung, S C Chung.   

Abstract

OBJECTIVES: To investigate whether smoking would increase ulcer recurrence after eradication of Helicobacter pylori (H. pylori) without maintenance acid-suppression therapy.
METHODS: A total of 287 patients, 256 patients with duodenal ulcers and 31 patients with gastric ulcers, were followed-up for up to 18 months after ulcer healing and successful eradication of H. pylori. There were 83 smokers (defined as smoking > or = 10 cigarettes/day) and 204 patients who never smoked or stopped smoking after the diagnosis of peptic ulcer disease. None were taking nonsteroidal anti-inflammatory drugs or receiving maintenance acid suppression therapy. Endoscopy was repeated either at the end of the follow-up period or when ulcer symptoms recurred.
RESULTS: Of the 83 smokers, 3 (3.6%) had ulcer recurrence, which included two duodenal ulcers and one gastric ulcer. Of the 204 nonsmokers, 4 (2.0%) had ulcer relapse, and all being recurrent duodenal ulcers. Four smokers (4.8%) and nine nonsmokers (4.4%) had recurrence of H. pylori infection after 10-18 months. There was no significant difference in ulcer relapse or recurrence of H. pylori infection between smokers and nonsmokers.
CONCLUSIONS: Cigarette smoking did not increase the recurrence of peptic ulcers after eradication of H. pylori.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068465

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

Review 1.  Perforated peptic ulcer - an update.

Authors:  Kin Tong Chung; Vishalkumar G Shelat
Journal:  World J Gastrointest Surg       Date:  2017-01-27

2.  Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults.

Authors:  S Rosenstock; T Jørgensen; O Bonnevie; L Andersen
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.